Merck COVID-19 pill could be 'huge step forward,' says specialist

Early results from an experimental COVID-19 pill that may significantly reduce hospitalization and deaths among some higher-risk patients shows promise, says infectious diseases specialist Dr. Matthew Oughton. He says molnupiravir could be a 'huge step forward' in treatment but seeing more raw data will allow experts to fully assess its effectiveness.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting